CM
STIM icon

Caption Management’s Neuronetics STIM Stock Holding History

Caption Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,501
Closed -$128K – 2037
2025
Q4 		$128K Buy
92,501
+78,723
+571% +$165K ﹤0.01% 1423
2025
Q3 		$37.6K Buy
+13,778
New +$48.9K ﹤0.01% 1576
2022
Q1 		– Sell
-35,897
Closed -$160K – 1923
2021
Q4 		$160K Hold
35,897
– – ﹤0.01% 1440
2021
Q3 		$235K Buy
+35,897
New +$344K ﹤0.01% 1323

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caption Management's STIM Position: Q1 2026 in Review

Caption Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 92,501 shares — an estimated $128K sold.

Caption Management first reported a position in STIM in Q3 2021 and held it in 4 quarters. The position peaked at $235K in Q3 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Caption Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 92,501 Neuronetics shares in Q1 2026, an estimated $128K.
  • Caption Management first reported a position in Neuronetics in Q3 2021 and held it in 4 quarters.
  • Caption Management's Neuronetics position peaked at $235K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.